NEW YORK, Dec 22 - Deltagen said Friday that it has signed Pfizer as the second licensee to its DeltaBase gene function database.

Under the terms of the agreement, Pfizer will have non-exclusive access to in vivo mammalian gene function information on 750 genes in DeltaBase, as well as access to corresponding DeltaBase intellectual property rights.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.